These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30014974)

  • 1. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors.
    Mao H; Bao T; Shen X; Li Q; Seluzicki C; Im EO; Mao JJ
    Eur J Cancer; 2018 Sep; 101():47-54. PubMed ID: 30014974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors.
    Desai K; Mao JJ; Su I; Demichele A; Li Q; Xie SX; Gehrman PR
    Support Care Cancer; 2013 Jan; 21(1):43-51. PubMed ID: 22584732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arthralgia among women taking aromatase inhibitors: is there a shared inflammatory mechanism with co-morbid fatigue and insomnia?
    Bauml J; Chen L; Chen J; Boyer J; Kalos M; Li SQ; DeMichele A; Mao JJ
    Breast Cancer Res; 2015 Jun; 17(1):89. PubMed ID: 26126656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.
    Romero SAD; Su HI; Satagopan J; Li QS; Seluzicki CM; Dries A; DeMichele AM; Mao JJ
    Breast; 2020 Feb; 49():48-54. PubMed ID: 31678641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Chen J; Mao JJ
    Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors.
    Chim K; Xie SX; Stricker CT; Li QS; Gross R; Farrar JT; DeMichele A; Mao JJ
    BMC Cancer; 2013 Sep; 13():401. PubMed ID: 24004677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
    Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
    J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Hong D; Bi L; Zhou J; Tong Y; Zhao Q; Chen J; Lu X
    Oncotarget; 2017 Jun; 8(25):40558-40567. PubMed ID: 28489562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study.
    Pedersini R; Monteverdi S; Mazziotti G; Amoroso V; Roca E; Maffezzoni F; Vassalli L; Rodella F; Formenti AM; Frara S; Maroldi R; Berruti A; Simoncini E; Giustina A
    Bone; 2017 Apr; 97():147-152. PubMed ID: 28104509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
    Lintermans A; Van Asten K; Wildiers H; Laenen A; Paridaens R; Weltens C; Verhaeghe J; Vanderschueren D; Smeets A; Van Limbergen E; Leunen K; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2014 Jul; 146(1):109-16. PubMed ID: 24816806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors.
    Su HI; Sammel MD; Springer E; Freeman EW; DeMichele A; Mao JJ
    Breast Cancer Res Treat; 2010 Nov; 124(1):205-11. PubMed ID: 20182796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.
    Mao JJ; Su HI; Feng R; Donelson ML; Aplenc R; Rebbeck TR; Stanczyk F; DeMichele A
    Breast Cancer Res; 2011 Jan; 13(1):R8. PubMed ID: 21251330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA; Speth KA; Kidwell KM; Lyden A; Alsamarraie C; Murphy SL; Henry NL
    Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment.
    Wang T; Huang YY; Liu XL; Molassiotis A; Yao LQ; Zheng SL; Tan JB; Huang HQ
    Support Care Cancer; 2022 Nov; 30(11):9279-9288. PubMed ID: 36065027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Gross R; Chen J; Mao JJ
    Cancer; 2017 Jan; 123(1):169-176. PubMed ID: 27570979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors.
    Nyrop KA; Callahan LF; Cleveland RJ; Arbeeva LL; Hackney BS; Muss HB
    Oncologist; 2017 Oct; 22(10):1238-1249. PubMed ID: 28698390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living with chronic pain: perceptions of breast cancer survivors.
    Bao T; Seidman A; Li Q; Seluzicki C; Blinder V; Meghani SH; Farrar JT; Mao JJ
    Breast Cancer Res Treat; 2018 May; 169(1):133-140. PubMed ID: 29350307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tai chi for well-being of breast cancer survivors with aromatase inhibitor-associated arthralgias: a feasibility study.
    Galantino ML; Callens ML; Cardena GJ; Piela NL; Mao JJ
    Altern Ther Health Med; 2013; 19(6):38-44. PubMed ID: 24254037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
    Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
    J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.